AAF-CMK

• Description :

  AAF-CMK is a TPPII (tripeptidylpeptidase II) inhibitor, shows anti-tumor activity and induces apoptosis. AAF-CMK can be used in leukemia research[1].

• UNSPSC :

  12352209

• Target :

  Apoptosis; Ser/Thr Protease

• Type :

  Peptides

• Related Pathways :

  Apoptosis; Metabolic Enzyme/Protease

• Applications :

  Cancer-Kinase/protease

• Field of Research :

  Cancer

• Assay Protocol :

  https://www.medchemexpress.com/aaf-cmk.html

• Solubility :

  10 mM in DMSO

• Smiles :

  C[C@H](N)C(N[C@@H](C)C(N[C@H](C(CCl)=O)CC1=CC=CC=C1)=O)=O

• Molecular Formula :

  C16H22ClN3O3

• Molecular Weight :

  339.82

• References & Citations :

  [1]Młnarczuk I, et al. AAF-cmk sensitizes tumor cells to trail-mediated apoptosis. Leuk Res. 2004 Jan;28 (1) :53-61.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Peptides

• Clinical Information :

  No Development Reported

• CAS Number :

  [102129-66-8]